Stopped: Homology Medicines has discontinued the development of this program.
The objective of this study is to characterize the natural history of phenylketonuria (PKU) due to phenylalanine hydroxylase (PAH) deficiency in adults through prospective collection of clinical, cognitive, and quality of life assessments.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Plasma phenylalanine (Phe) concentrations
Timeframe: Baseline to Week 52
Plasma tyrosine (Tyr) concentrations
Timeframe: Baseline to Week 52
Quality of life (QOL), as assessed using the PKU-QOL questionnaire measures
Timeframe: Baseline to Week 52